Christian Behrenbruch

Dr. Behrenbruch has more than two decades of radiopharmaceuticals experience and a track record in global healthcare and biotechnology entrepreneurship and technology commercialization. He brings a blend of technical expertise and executive leadership to guide Telix as it enters the next stage of its strategy. Dr. Behrenbruch has a focus on purpose and values-leadership, and is versed in all aspects of running a publicly listed company as both CEO and Director in the U.S. and Australia. Previously, Dr. Behrenbruch served as Chief Executive Officer at Mirada Solutions (now Mirada Medical Limited) (from July 2001 to December 2002), President at CTI Molecular Imaging (now Siemens Healthcare) (from August 2003 to September 2006), Chief Executive Officer at Fibron Technologies, Inc. (from June 2008 to December 2011) and Chief Executive Officer at ImaginAb, Inc. (from October 2007 to February 2015). He served as a Director at Siemens Molecular Imaging Ltd (from May 2005 to September 2006), Momentum Biosciences LLC (from July 2007 to June 2009), Radius Health Ltd (now Adaptix Ltd) (from May 2009 to February 2011). Dr. Behrenbruch was the Chairman of Cell Therapies Pty Ltd (a partnership with the Peter MacCallum Cancer Centre) (from October 2012 to July 2014). He is member of Disclosure Commitee.